Beneath the Veneer: The Troubled Past and Future of Sexual Medicine
L. Tiefer
DOI: https://doi.org/10.1080/00926230701480521
2007-08-02
Journal of Sex & Marital Therapy
Abstract:My presidential address to the International Academy of Sex Research in 1993, 5 years before Viagra was released to the world, was entitled “Three Crises Facing Sexology” (Tiefer, 1994). One of the crises, a subject on which I had been publishing since 1986, 12 years before Viagra, was the medicalization of sexology (Tiefer, 1986). Ah, the joys of being ahead of one’s time! Using sociological notions of medicalization and disease-mongering (Conrad, 2007; Payer, 1992), I have analyzed, over the past 20 years, how urologists, funded by an ambitious pharmaceutical industry assisted by favorable government policies such as direct-to-consumer advertising and poor oversight of conflicts of interest, created a new but thin subspecialty, “sexual medicine” (Tiefer, 2004, 2006a). In the present essay under comment, Rowland (2007) errs in regarding this new “sexual medicine” as if it were an established clinical subspecialty, rather than merely the brand-name for a product being aggressively promoted by a multi-billion dollar industry. His analysis of the weaknesses of “sexual medicine” would be alarming if not for this fundamental error. It’s as if he went to extraordinary lengths to analyze the advantages and disadvantages of alchemy. Over the past decade the pharmaceutical industry has spent billions to persuade professionals and the public that its leaden sex research is actually gold, in fact “gold standard.” Much of the research in Rowland’s figures is the result of this industry pseudoscience. Fortunately, the huge marketing machine of sponsored research, sponsored professional continuing education, sponsored lunches, sponsored organizations, sponsored dinner talks, sponsored workshops, sponsored awards, sponsored speakers’ bureaus, sponsored conferences, sponsored journals, and other forms of gifts and entanglements by which the pharmaceutical industry pushes its brands is at last beginning to unravel (Abramson, 2004; Angell, 2004; Avorn, 2004; Critser, 2005; Kassirer, 2005; Moynihan, 2003a, 2003b; Moynihan & Cassels, 2005).